MEDICUS PHARMA LTD.

MEDICUS PHARMA LTD.

Share · CA58471K2020 · MDCX · A40PMQ (XTSX)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of MEDICUS PHARMA LTD.
No Price
29.04.2026 08:43
Current Prices from MEDICUS PHARMA LTD.
ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
MDCX
USD
29.04.2026 08:43
0,29 USD
-0,01 USD
-3,37 %
IEXG: IEX
IEX
MDCX
USD
28.04.2026 19:59
0,30 USD
0,003 USD
+0,88 %
Company Profile for MEDICUS PHARMA LTD. Share
Medicus Pharma Ltd. is a biotech/life sciences company focused on accelerating the clinical development programs of novel and disruptive therapeutic assets, with an emphasis on non-invasive treatments for skin cancer.

Company Data

Name MEDICUS PHARMA LTD.
Company Medicus Pharma Ltd. Common Stock
Symbol MDCX
Website https://medicuspharma.com
Primary Exchange XTSX Frankfurt
WKN A40PMQ
ISIN CA58471K2020
Asset Class Share
Sector Healthcare
Industry Biotechnology
CEO Raza Bokhari MBA
Country Canada
Currency EUR
Employees 0,0 T
Address 300 Conshohocken State Rd. Suite 200, 19428 W. Conshohocken
IPO Date 2024-11-15

Ticker Symbols

Name Symbol
Frankfurt N460.F
NASDAQ MDCX
More Shares
Investors who hold MEDICUS PHARMA LTD. also have the following shares in their portfolio:
BMO High Yield US Corporate Bond Hedged to CAD Index ETF
BMO High Yield US Corporate Bond Hedged to CAD Index ETF ETF
MORGAN STANLEY EQTY LKD CERTS 19/10/22
MORGAN STANLEY EQTY LKD CERTS 19/10/22 Bond